Age-specific Antibody to Hepatitis E Virus Has Remained Constant During the Past 20 Years in Japan
Overview
Affiliations
We investigated the presence of antibodies to hepatitis E virus (anti-HEV) and hepatitis A virus (anti-HAV) by enzyme immunoassays in sera from 1015 individuals collected in 1974, 1984 and 1994. Age-specific profiles of anti-HEV remained unchanged with a peak at 40-49 years, while those of anti-HAV started to increase in individuals aged 20-29 years in 1974, 30-39 years in 1984 and 40-49 years in 1994. These results suggest that a silent HEV infection has been taking place in the last 20 years or so in Japan, while HAV infection has been terminated at least since 1974.
Gu G, Huang H, Zhang L, Bi Y, Hu Y, Zhou Y BMC Infect Dis. 2015; 15:560.
PMID: 26653888 PMC: 4675061. DOI: 10.1186/s12879-015-1308-y.
Lee J, Shao P, Chang L, Xia N, Chen P, Lu C PLoS One. 2013; 8(6):e67180.
PMID: 23840620 PMC: 3694024. DOI: 10.1371/journal.pone.0067180.
Hepatitis E: a complex and global disease.
Pelosi E, Clarke I Emerg Health Threats J. 2012; 1:e8.
PMID: 22460217 PMC: 3167588. DOI: 10.3134/ehtj.08.008.
Zhang W, Yang S, Ren L, Shen Q, Cui L, Fan K PLoS One. 2009; 4(12):e8156.
PMID: 19997619 PMC: 2785466. DOI: 10.1371/journal.pone.0008156.
Kuniholm M, Purcell R, McQuillan G, Engle R, Wasley A, Nelson K J Infect Dis. 2009; 200(1):48-56.
PMID: 19473098 PMC: 2762746. DOI: 10.1086/599319.